Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease

Trial N/A Completed March 3, 2020

The Impact of a Diagnosis of Parkinson's on Work

Trial N/A Completed March 2, 2020

Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease

Trial Phase 1 Completed March 2, 2020

LIPAD - LRRK2 International Parkinson's Disease Study

Trial N/A Unknown Feb. 26, 2020

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Trial Phase 2 Completed Feb. 26, 2020

Frequency Effect of STN-DBS Through the Dual System on FOG in PD

Trial N/A Unknown Feb. 25, 2020

Rapid Cadence Cycling for Parkinson's Disease: A Study of Implementation and Efficacy in the Community Setting

Trial N/A Completed Feb. 24, 2020

Cognitive Behavioural Therapy for Anxiety Disorders in PD

Trial N/A Completed Feb. 18, 2020

Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease

Trial N/A Completed Feb. 17, 2020

The Learning Effects of Attentional Strategy on Dual-task Walking in Patients With Parkinson's Disease: Behavioral Performance and Neural Plasticity

Trial N/A Terminated Feb. 12, 2020

NAD-supplementation in Drug naïve Parkinson's Disease

Trial N/A Completed Feb. 11, 2020

ParKinWalk: Physical Activity and Long Group-walking for Parkinson's Disease

Trial N/A Completed Feb. 11, 2020

Diagnosis of Parkinson´s Disease by Means of Submandibular Gland Needle Biopsy

Trial N/A Unknown Feb. 11, 2020

Role of Deep Brain Stimulation on Social Cognition in Parkinsonian Patients

Trial N/A Completed Feb. 10, 2020

Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)

Trial Phase 1 Completed Feb. 10, 2020

Is Long-term Use of Amantadine Effective in PD?

Trial N/A Unknown Feb. 6, 2020

On-line Cognitive Training for Parkinson's Disease

Trial N/A Unknown Feb. 6, 2020

The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) Patients

Trial N/A Completed Feb. 5, 2020

A Positron Emission Tomography (PET) Study to Examine the Brain Binding Properties of a Novel Radioactive Compound [11C]-PXT012253 in Healthy Subjects

Trial Early Phase 1 Completed Feb. 4, 2020

Neuropsychological Assessment of Cognitive Decline in Patients With a Definite Parkinson's Disease

Trial N/A Completed Feb. 4, 2020